Transanal total mesorectal excision: short- and long-term results of four certified colorectal cancer centers in Germany.

ABSTRACT:

Background

Transanal total mesorectal excision (TaTME), a novel approach for treating low rectal cancer, holds promise. However, concerns exist in certain countries about their oncologic safety due to less-than-optimal outcomes on global studies. This research seeks to evaluate the long-term oncologic outcomes focusing on local recurrence rate and overall survival after TaTME surgery in Germany.

Patients and methods

This study analyzed data from patients who underwent elective TaTME surgery between 2014 and 2021 in four certified colorectal cancer centers in Germany. Primary endpoints were 3-year local recurrence rate and local recurrence-free survival (LRFS). Secondary outcomes encompassed overall survival (OS), operative time, completeness of local tumor resection, lymph n

SUBMITTER: Grundler E 

PROVIDER: S-EPMC11327187 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature